The Falk Transformational Research Award from Health Resources in Action funds advanced translational biomedical research to move discoveries from the lab toward clinical treatments and cures.
Falk Catalyst Research Award Program supports biomedical research teams with seed funding to overcome therapeutic roadblocks and advance promising innovations toward clinical practice in the near term.
2025 Translational Research Award supports established investigators studying breast cancer metastases to develop better treatments and improve outcomes for people living with stage IV disease.
New Translational Science Tools and Methodologies Award supports research teams developing generalizable tools to improve preclinical development, evaluation, and real-time monitoring of clinical efficacy.
The American Lung Association Catalyst Research Award funds early-career researchers pursuing innovative, mentored studies in lung disease mechanisms and lung biology.
The Kyle Bryant Translational Research Award supports Friedreich’s ataxia investigators developing therapies, biomarkers, clinical measures, and tools that move research toward clinical use.